European HTA agencies launch the Heads of Agencies Group (HAG)
FDA-EMA Parallel Scientific Advice Pilot program for complex generic/hybrid products
Value-based pricing of prescription drugs benefits patients and promotes innovation
We provide an overview of the product life cycle
French government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...
Learn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.